Arcutis Biotherapeutics, Inc. (ARQT)
23.79
+0.41
(+1.75%)
USD |
NASDAQ |
Sep 11, 13:46
Arcutis Biotherapeutics Gross Profit (TTM) : 422.88M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 422.88M |
| March 31, 2026 | 377.98M |
| December 31, 2025 | 339.38M |
| September 30, 2025 | 286.02M |
| June 30, 2025 | 234.74M |
| March 31, 2025 | 188.12M |
| December 31, 2024 | 177.41M |
| September 30, 2024 | 124.04M |
| June 30, 2024 | 121.52M |
| March 31, 2024 | 98.25M |
| December 31, 2023 | 53.94M |
| September 30, 2023 | 45.09M |
| June 30, 2023 | 8.58M |
| March 31, 2023 | 4.218M |
| December 31, 2022 | 1.991M |
| September 30, 2022 | -0.454M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.866M |
| March 31, 2022 | -0.814M |
| December 31, 2021 | -0.763M |
| September 30, 2021 | -0.718M |
| June 30, 2021 | -0.693M |
| March 31, 2021 | -0.568M |
| December 31, 2020 | -0.455M |
| September 30, 2020 | -0.349M |
| June 30, 2020 | -0.317M |
| March 31, 2020 | -0.347M |
| December 31, 2019 | -0.306M |
| September 30, 2019 | -0.246M |
| June 30, 2019 | -0.111M |
| March 31, 2019 | -0.024M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Insmed, Inc. | 941.78M |
| Emergent BioSolutions, Inc. | 363.30M |
| Exelixis, Inc. | 2.350B |
| Vertex Pharmaceuticals, Inc. | 10.94B |